ELEMU MEDICAL: what changed
Position among the sector peers
Sector benchmark: create a free account or sign in to use this tool.
You see every sector peer as a dot per ratio, with the company in two financial years and every ratio over five years against the sector.
What moved between 2023 and 2024
Largest movements
No asset line moved by more than 1% of the balance sheet total.
- Tax, wage and social debts -€24,123
down €24,123 (-37.8%), from €63,820 to €39,698
- Reserves +€21,455
up €21,455 (+8.1%), from €266,226 to €287,681
- Gross operating margin -€33,973
down €33,973 (-57.7%), from €58,908 to €24,935
- Taxes -€9,536
down €9,536 (-49.8%), from €19,160 to €9,625
- Other operating charges +€1,795
up €1,795 (+520%), from €345 to €2,140
- Financial charges -€1,440
down €1,440 (-50.4%), from €2,858 to €1,419
- Financial income +€1,220
up €1,220 (+13.1%), from €9,316 to €10,537
Change in the result, 2023 to 2024
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2023 and 2024 balance sheets and the 2024 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €338,885 | €339,264 | +€379 | +0.1% |
| Current assets | 29/58 | €338,885 | €339,264 | +€379 | +0.1% |
| Amounts receivable after more than one year | 29 | €260,000 | €260,000 | = | 0.0% |
| Other amounts receivable | 291 | €260,000 | €260,000 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €71,532 | €71,768 | +€236 | +0.3% |
| Trade receivables | 40 | €14,442 | €4,611 | -€9,831 | -68.1% |
| Other amounts receivable | 41 | €57,089 | €67,157 | +€10,067 | +17.6% |
| Cash at bank and in hand | 54/58 | €310 | €452 | +€142 | +46.0% |
| Deferred charges and accrued income | 490/1 | €7,044 | €7,044 | = | 0.0% |
| Total equity and liabilities | 10/49 | €338,885 | €339,264 | +€379 | +0.1% |
| Equity | 10/15 | €267,226 | €288,681 | +€21,455 | +8.0% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €266,226 | €287,681 | +€21,455 | +8.1% |
| Distributable reserves | 133 | €266,226 | €287,681 | +€21,455 | +8.1% |
| Amounts payable | 17/49 | €71,659 | €50,583 | -€21,076 | -29.4% |
| Amounts payable within one year | 42/48 | €71,659 | €50,583 | -€21,076 | -29.4% |
| Trade debts | 44 | €7,839 | €10,885 | +€3,047 | +38.9% |
| Suppliers | 440/4 | €7,839 | €10,885 | +€3,047 | +38.9% |
| Taxes, remuneration and social security | 45 | €63,820 | €39,698 | -€24,123 | -37.8% |
| Taxes | 450/3 | €63,820 | €39,698 | -€24,123 | -37.8% |
| Non-recurring operating income | 76A | - | €76 | +€76 | |
| Other operating charges | 640/8 | €345 | €2,140 | +€1,795 | +520% |
| Non-recurring operating charges | 66A | - | €833 | +€833 | |
| Gross operating margin | 9900 | €58,908 | €24,935 | -€33,973 | -57.7% |
| Operating profit (loss) | 9901 | €58,563 | €21,961 | -€36,602 | -62.5% |
| Financial income | 75/76B | €9,316 | €10,537 | +€1,220 | +13.1% |
| Recurring financial income | 75 | €9,316 | €10,537 | +€1,220 | +13.1% |
| Financial charges | 65/66B | €2,858 | €1,419 | -€1,440 | -50.4% |
| Recurring financial charges | 65 | €2,858 | €1,419 | -€1,440 | -50.4% |
| Profit (loss) for the period before taxes | 9903 | €65,021 | €31,080 | -€33,941 | -52.2% |
| Income taxes | 67/77 | €19,160 | €9,625 | -€9,536 | -49.8% |
| Profit (loss) for the period | 9904 | €45,860 | €21,455 | -€24,406 | -53.2% |
| Profit (loss) for the period to be appropriated | 9905 | €45,860 | €21,455 | -€24,406 | -53.2% |
Value
latest balance sheet 31-12-2024 · indication, not a valuation or adviceIndicative value of the equity
Indication, not a valuation or adviceMidpoint €338,920 · 50% capitalised earnings, 50% adjusted equity
Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50% revaluation €0 other adjustment €0 EBITDA multiple
The filed figures and these assumptions give no positive value. The adjusted equity and the average result are both zero or negative.
Part of the calculation comes out below zero. A shareholding is never worth less than zero, so the floor is zero.
Adjusted equity
- Equity (10/15)
- €288,681
- Formation expenses (20)
- €0
- Intangible fixed assets (21)
- €0
- Revaluation of assets
- €0
- Deferred tax on the revaluation
- €0
- Other adjustment
- €0
- Adjusted equity
- €288,681
Capitalised earnings
- 2024
- €21,455
- excluding non-recurring income and charges
- €22,212
- 2023
- €45,860
- 2022
- €72,024
- 2021
- €83,281
- 2020
- €70,300
- Average result, excluding non-recurring income and charges
- €46,699
- Divided by the capitalisation rate
- 14% / 12% / 10%
- Capitalised earnings
- €333,564 / €389,158 / €466,990
Your EBITDA multiple
- EBITDA 2024
- -
- Net financial debt
- -€452
- Your multiple
- -
- Value with your multiple
- -
These accounts do not break down the debts after one year. They count in full as financial debt.
Limits of the indication
- Checked holds no market prices or comparable transactions.
- Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
- Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
- The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.
For a valuation to base a decision on, go to a company auditor or a certified accountant.
Next steps
Calculation and sources
Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2023 and 31 December 2024. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 14 November 2026 via checked.be.